IE890079L - Method for increasing enzyme activities and synthesis performance of organisms - Google Patents
Method for increasing enzyme activities and synthesis performance of organismsInfo
- Publication number
- IE890079L IE890079L IE890079A IE7989A IE890079L IE 890079 L IE890079 L IE 890079L IE 890079 A IE890079 A IE 890079A IE 7989 A IE7989 A IE 7989A IE 890079 L IE890079 L IE 890079L
- Authority
- IE
- Ireland
- Prior art keywords
- elicitor
- microorganisms
- atcc
- fragments
- bacteria
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 37
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 title claims description 28
- 244000005700 microbiome Species 0.000 claims abstract description 65
- 239000005712 elicitor Substances 0.000 claims abstract description 56
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 239000012634 fragment Substances 0.000 claims abstract description 20
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 12
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 12
- 229930013930 alkaloid Natural products 0.000 claims abstract description 8
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000280 phytoalexin Substances 0.000 claims abstract description 7
- 150000001857 phytoalexin derivatives Chemical class 0.000 claims abstract description 7
- 150000003431 steroids Chemical class 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 28
- 230000028327 secretion Effects 0.000 claims description 15
- 230000002708 enhancing effect Effects 0.000 claims description 10
- 239000000975 dye Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 claims 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 230000029142 excretion Effects 0.000 abstract 2
- 239000000049 pigment Substances 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 22
- 210000002421 cell wall Anatomy 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- 230000000638 stimulation Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 241000186216 Corynebacterium Species 0.000 description 10
- 238000007792 addition Methods 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241000186146 Brevibacterium Species 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000187747 Streptomyces Species 0.000 description 6
- 241000187398 Streptomyces lividans Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- VTIKDEXOEJDMJP-UHFFFAOYSA-N Actinorhodine Natural products CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)c(cc(O)c3C2=O)c4cc(O)c5C(=O)C6=C(C(C)OC(CC(=O)O)C6)C(=O)c5c4O VTIKDEXOEJDMJP-UHFFFAOYSA-N 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- HCOLPNRPCMFHOH-UHFFFAOYSA-N Prodigiosin Natural products CCCCCC1C=C(C=C/2N=C(C=C2OC)c3ccc[nH]3)N=C1C HCOLPNRPCMFHOH-UHFFFAOYSA-N 0.000 description 5
- 241000187694 Rhodococcus fascians Species 0.000 description 5
- VTIKDEXOEJDMJP-WYUUTHIRSA-N actinorhodin Chemical compound C([C@@H](CC(O)=O)O[C@@H]1C)C(C(C2=C(O)C=3)=O)=C1C(=O)C2=C(O)C=3C(C(=C1C2=O)O)=CC(O)=C1C(=O)C1=C2[C@@H](C)O[C@H](CC(O)=O)C1 VTIKDEXOEJDMJP-WYUUTHIRSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 229960001031 glucose Drugs 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- TWFGRJUTAULJPZ-USZBIXTISA-N prodigiosin Chemical compound N1=C(C)C(CCCCC)=C\C1=C/C1=NC(C=2[N]C=CC=2)=C[C]1OC TWFGRJUTAULJPZ-USZBIXTISA-N 0.000 description 5
- 241000193422 Bacillus lentus Species 0.000 description 4
- 241000124224 Claviceps paspali Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- ZAGRKAFMISFKIO-UHFFFAOYSA-N Isolysergic acid Natural products C1=CC(C2=CC(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-UHFFFAOYSA-N 0.000 description 4
- 241000233614 Phytophthora Species 0.000 description 4
- 241000223253 Rhodotorula glutinis Species 0.000 description 4
- 241000187433 Streptomyces clavuligerus Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- GENAHGKEFJLNJB-QMTHXVAHSA-N lysergamide Chemical compound C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(N)=O)=C3C2=CNC3=C1 GENAHGKEFJLNJB-QMTHXVAHSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000000844 transformation Methods 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- ZAGRKAFMISFKIO-IINYFYTJSA-N (6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxylic acid Chemical compound C1=CC(C2=C[C@@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-IINYFYTJSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241001070171 Corynebacterium striatum ATCC 6940 Species 0.000 description 2
- 241000186245 Corynebacterium xerosis Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 244000001381 Eschscholzia californica Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 244000061121 Rauvolfia serpentina Species 0.000 description 2
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 description 2
- 241000187217 Streptomyces griseoruber Species 0.000 description 2
- 241000187410 Streptomyces purpurascens Species 0.000 description 2
- 241000187175 Streptomyces violaceus Species 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 241000319304 [Brevibacterium] flavum Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- -1 bibenzyls Chemical class 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 229930005303 indole alkaloid Natural products 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- ZAGRKAFMISFKIO-QMTHXVAHSA-N lysergic acid Chemical class C1=CC(C2=C[C@H](CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 ZAGRKAFMISFKIO-QMTHXVAHSA-N 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- RJNCJTROKRDRBW-TZMCWYRMSA-N (6ar,10ar)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinoline-7-ium-9-carboxylate Chemical compound C1=CC([C@H]2C=C(CN([C@@H]2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-TZMCWYRMSA-N 0.000 description 1
- WEEFNMFMNMASJY-UHFFFAOYSA-M 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 WEEFNMFMNMASJY-UHFFFAOYSA-M 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- HXMZLDUBSSPQIB-UHFFFAOYSA-N 2-phenyl-1-benzofuran Chemical class O1C2=CC=CC=C2C=C1C1=CC=CC=C1 HXMZLDUBSSPQIB-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- XJOOMMHNYOJWCZ-UHFFFAOYSA-N Agroclavine Natural products C1=CC(C2C=C(C)CN(C2C2)C)=C3C2=CNC3=C1 XJOOMMHNYOJWCZ-UHFFFAOYSA-N 0.000 description 1
- 241000027112 Alternaria carthami Species 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241001274890 Boeremia exigua Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 241000221868 Ceratocystis fimbriata Species 0.000 description 1
- LLEJIEBFSOEYIV-UHFFFAOYSA-N Chelerythrine Natural products C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 241000593872 Chondrostereum Species 0.000 description 1
- 241001133184 Colletotrichum agaves Species 0.000 description 1
- 241001120669 Colletotrichum lindemuthianum Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 108010036941 Cyclosporins Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- NESVMZOPWPCFAU-UHFFFAOYSA-N Ergoclavinine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C)C2)=C3C2=CNC3=C1 NESVMZOPWPCFAU-UHFFFAOYSA-N 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- SAHHMCVYMGARBT-UHFFFAOYSA-N Isochanoclavine I Natural products C1=CC(C(C(NC)C2)C=C(C)CO)=C3C2=CNC3=C1 SAHHMCVYMGARBT-UHFFFAOYSA-N 0.000 description 1
- MIFYHUACUWQUKT-UHFFFAOYSA-N Isopenicillin N Natural products OC(=O)C1C(C)(C)SC2C(NC(=O)CCCC(N)C(O)=O)C(=O)N21 MIFYHUACUWQUKT-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241001518731 Monilinia fructicola Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- 241001226034 Nectria <echinoderm> Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000187580 Nocardioides Species 0.000 description 1
- QQENBDLCKJUZGC-UHFFFAOYSA-N O.O.B([O-])([O-])O.B(O)(O)O.B(O)(O)O.B(O)(O)O.[Na+].[Na+] Chemical compound O.O.B([O-])([O-])O.B(O)(O)O.B(O)(O)O.B(O)(O)O.[Na+].[Na+] QQENBDLCKJUZGC-UHFFFAOYSA-N 0.000 description 1
- 241000221671 Ophiostoma ulmi Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000985516 Penicillium raistrickii Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 241000233616 Phytophthora capsici Species 0.000 description 1
- 241000233624 Phytophthora megasperma Species 0.000 description 1
- 241000203722 Pimelobacter Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000187603 Pseudonocardia Species 0.000 description 1
- 241001123561 Puccinia coronata Species 0.000 description 1
- VLMZMRDOMOGGFA-PSOPSSQASA-N Pyroclavine Natural products C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-PSOPSSQASA-N 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- 241000208332 Rauvolfia Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001611093 Stimula Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000007994 TES buffer Substances 0.000 description 1
- 241000866060 Terrabacter tumescens Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 241001123669 Verticillium albo-atrum Species 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 229950008644 adicillin Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- YDOTUXAWKBPQJW-UHFFFAOYSA-N alpha-Ergocryptinine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-UHFFFAOYSA-N 0.000 description 1
- YDOTUXAWKBPQJW-NSLWYYNWSA-N alpha-ergocryptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-NSLWYYNWSA-N 0.000 description 1
- 229950001817 alpha-ergocryptine Drugs 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Chemical compound C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- RNSBFHHWMMKJAM-UHFFFAOYSA-N chelirubine Chemical compound C12=C[N+](C)=C3C4=CC=5OCOC=5C=C4C=CC3=C2C(OC)=CC2=C1OCO2 RNSBFHHWMMKJAM-UHFFFAOYSA-N 0.000 description 1
- QRCWKBAFKDYSFR-UHFFFAOYSA-N chelirubine Natural products COc1cc2cc3OCOc3cc2c4N(C)C(O)c5c6OCOc6ccc5c14 QRCWKBAFKDYSFR-UHFFFAOYSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 description 1
- 150000001907 coumarones Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- RJNCJTROKRDRBW-UHFFFAOYSA-N d-paspalic acid Natural products C1=CC(C2C=C(CN(C2C2)C)C(O)=O)=C3C2=CNC3=C1 RJNCJTROKRDRBW-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- OWEUDBYTKOYTAD-MKTPKCENSA-N ergocristine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(N21)=O)(NC(=O)[C@@H]1C=C2C3=CC=CC4=NC=C([C]34)C[C@H]2N(C)C1)C(C)C)C1=CC=CC=C1 OWEUDBYTKOYTAD-MKTPKCENSA-N 0.000 description 1
- HEFIYUQVAZFDEE-UHFFFAOYSA-N ergocristinine Natural products N12C(=O)C(C(C)C)(NC(=O)C3C=C4C=5C=CC=C6NC=C(C=56)CC4N(C)C3)OC2(O)C2CCCN2C(=O)C1CC1=CC=CC=C1 HEFIYUQVAZFDEE-UHFFFAOYSA-N 0.000 description 1
- NESVMZOPWPCFAU-ZPRCMDFASA-N ergosine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C)C2)=C3C2=CNC3=C1 NESVMZOPWPCFAU-ZPRCMDFASA-N 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical class [H]C#C* 0.000 description 1
- VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- ZDPUTNZENXVHJC-UUOKFMHZSA-N guanosine 3'-monophosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O ZDPUTNZENXVHJC-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- MIFYHUACUWQUKT-GTQWGBSQSA-N isopenicillin N Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2[C@H](NC(=O)CCC[C@H](N)C(O)=O)C(=O)N21 MIFYHUACUWQUKT-GTQWGBSQSA-N 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 150000002731 mercury compounds Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- MIFYHUACUWQUKT-GPUHXXMPSA-N penicillin N Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2[C@H](NC(=O)CCC[C@@H](N)C(O)=O)C(=O)N21 MIFYHUACUWQUKT-GPUHXXMPSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003432 sterols Chemical group 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- RVUXIPACAZKWHU-UHFFFAOYSA-N sulfuric acid;heptahydrate Chemical compound O.O.O.O.O.O.O.OS(O)(=O)=O RVUXIPACAZKWHU-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- KVMMLFSIULLRDK-UHFFFAOYSA-L zinc dichloride heptahydrate Chemical compound O.O.O.O.O.O.O.[Cl-].[Cl-].[Zn+2] KVMMLFSIULLRDK-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fertilizers (AREA)
Abstract
In the process disclosed, the organisms are brought into contact witn inactivated elicitor-containing microorganisms, fragments of the latter, or excretions of elicitor-containing microorganisms. Only inactivated elicitor-containing bacteria, fragments of the latter, or excretions of elicitor-containing bacteria may be used to activate enzymes and promote synthesis in non-microbial organisms. The process can be used, for example, to promote synthesis in microorganisms or plants which produce pigments, antibiotics, alkaloids or phytoalexins or to activate enzymes in microorganisms capable of transforming steroids.
Description
The invention relates to a method of enhancing enzyme activities and the synthetic capacity of microorganisms and higher plants,, which is characterised in that the same are brought into contact with inactivated elicitor-containing microorganisms, fragments of the same or secretions of elicitor-containing microorganisms, with the proviso that, in order to enhance enzyme activities and the synthetic capacity of higher plants,, inactivated elicitor-containing bacteria, fragments of the sasae or secretions of elicitor-containing bacteria ara used.
As is known, elicitors are microbial or plant active ingredients which, when brought into contact with tissues of higher plants, enhance the latter's enzyme activities and synthetic capacity. The components so accumulated in those plants are termed phytoalexins if they are antimicrobial (Naturwissenschaften, 68, 1981, 447ff, Adv. Enzymol. 55. 1983, Iff and Spektrum der Wissenschaft IX, 1985, 85ff).
At present, more than 100 compounds that satisfy the definition of phytoalexins have been isolated from various plant species. They belong to various groups of natural substances, such as terpenoids, linolanic acid derivatives, acetylenes and polyacetylenes, bibenzyls, stilbenes, phenanthrenes and dihydrophenanthrenes, benzofurans and phenolbenzofurans, furocumarins, avenalu mines, flavans, phenylbenzofurans, benzoxaainones, alkaloids, isoflavonoids (Brooks and Watson, Nat. Prod. Reports 2„ 1985, 427).
Hitherto, that elicitor action has not found any industrial application, for several reasons: with a few excep tions, it has hitherto not been possible to propagate cells of higher plants in submerged cultures under economically acceptable conditions. A priori.. it seesaed pointless to use elicitors in fermentation by means of microorganisms because, on the basis of the prevailing expert opinion regarding the mode of action of elicitors (Albersheia P. and Darvill A.G. Spektrua der wissen-schaft, JJL* 1985 , 85) it had to toe assumed that elicitors did not influence enzyme activity and the metabolic processes in microorganisms - It should also be noted that, according to the accepted expert opinion, bacteria, for example representatives of the genus Erwinia, can induce the formation of phytoalexins in plants only by freeing elicitors (oligogalact-urorsids) from the plant cell wall by means of specific enzymes (pectinases), which elicitors, as endogenous elicitors, stimulate the formation of phytoalexins• It has now been found that compounds and cell preparations of microorganisms , which are referred to in the following as elicitors, are, after all, surprisingly capable of enhancing enzyme activities in microorganisms and of enhancing the latter's synthetic capacity. In addition, it has been found that there are also bacteria that contain elicitors that are not enzymes or nutritive factors.
In principle, the method according to the invention can be carried out by means of isolated or synthesised elicitors, but that is generally far too complicated. It is sufficient to use inactivated elicitor-containing microorganisms, or fragments of those microorganisms, such as£, for example, cell wall fractions, cell fragments cf mechanically disrupted or chemically or enzymaticallv lysed cells, or cell components precipitated by auxiliaries, such as, for example, ethanol or acetone. Inactivated microorganisms within the context of the invention are those ?*itich have lost their viability permanently. - 3 - If the microorganism releases elicitors into the culture medium, or forms water-soluble elicitor-containing cell components after lysis or sterilisation,, those eliciror-containing secretions of the microorganisms can also be 5 used to carry out. the method according to the invention „ Any form of elicitar-containing product of microorganisms is suitable for carrying out the method according to the invention. 10 Microorganisms that are known to possess elicitors are, inter alia, the fungal strains and yeasts listed in the following Table 1: Table 1 Alternaria carthami Botrytis cinerea (ATCC 48345) Ceratocystis fimbriata Ceratocystis ulmi Chondrostereum purpureuin Cladosporium fulvum (ATCC 4 4 961) Colletotrichum lindemuthianum (ATCC 52471) Fusariuni sol ani Fusarium solanifspntori (ATCC 449J4 ) Ganoderma applanation Glomerella cingulata Hslminthosporium carbonum {ATCC 52471) Monilinia fructicola Nectria haeroatococca Phoma exigua Phytophthora cannabivora Phytophthora capsici (ATCC 52771) Phytophthora i nf eetam-. (ATCC 4 4 776 ) Phytophthora megaspermd var tjlycinea Phytophthora infectans Phytophthora megasperma Phytophthora nicotians Puccinia coronata Pyricularia oryzae (ATCC 15923) Saccharomyces cerevlslae Verticillium albo-atrum Verticil1lum dahliae (ATCC 26289) Arch. Bioch. Biop. 229. 1984, 136 Physiol, Plant Pathol. f 1977, 207 Phytochemistry 21, 1984, 759 Phytochemistry U, 1984, 38 3 J. Cham. Soc. Psrkin Trans I, 1984, 14 341 Physiol. Plant Pathol. ]J( 1980, 391 Eur. J. Biochem. 122t 1983, 593 Plant Physiol. 76, 1984, 833 Nat. Prod. Rep. 2, 1985, 439 Phytochemistry 22, 1983, 1039 Physiol, Plant Pathol. 21, 1982, 171 Z< Naturforsch. Sect. C 18, 1983, 899 J. Am. Cham. Soc., §4, 1962, 1919 ' Phytochemistry 2J, 3.983, 2291 * Phytochem. H, 1902, 1818 , Z. Naturf. Sect. C. IS, 1984, 217 Physiol. Plant Pathol, 18, 198.1, 379 Phytochem. 23, 1984, 537 Arch. Bioch. Bioph. , 1984, 136 Phytopathol. Z, 27, 1956, 237 J. Biol. Chem. 259, 1904, 11.341 Phytopathology 7J, 1901, 864 Physiol. Plant Pathol. 29, 1982, 189 Agric. Biol. Chem. 43, 1984, 253 Plant Physiol. §2, 1978, 107 Nat. Prod. Rep. g, 1905, 429 ATCC catalogue, 16th ed. 1984 In our own tests, cell wall preparations, purified proteolytically by trypsin, of gram-positive bacterial strains of the genera Bacillus,, Corynebacterium, Brevi-bacterium, Celluloraonas, Lactobacillus, Pimelobacter, Rhodococcus and Staphylococcus and microorganisms of those genera heat-sterilised in water and the filtrates thereof were investigated to establish whether they possess elicitors™ Table 2 below lists the bacterial strains in which elicitors were detected.
Table 2 Bacillus licheniforalis ATCC 9945 Bacillus puxnilus ATCC 7061 Brevibacteriua butanicuas ATCC 21196 Brevibacterium flavum ATCC 13826, ATCC 14067 Brevibacterium lactofermentmn ATCC 13655 Brevibacteriuxa glutamingenes ATCC 13747 Brevibacteriu® asononiagenes ATCC 6872 Corynebacterium hydrocarboc 1 as turn ATCC 15592 Corynebacteriura nephridii ATCC 11425 Corynebacteriumi pauroiaetabolum ATCC 8368 Corynebacterium 1 ilium ATCC 15990 CorynebacteriuM striatum ATCC 6940 Corynebacterium xerosis ATCC 373 Corynebacteriura diphtheria® (strain Mass. 8/Behring Werke) Corynebacterium saelassecola ATCC 17965 Corynebacteriusa gluraraicuffl ATCC 13032 CorynebacteriuM uracoxidans ATCC 21749 Lactobacillus casei subsp. rhaianosus ATCC 7469 Lactobacillus plantarum DSM 20174 Pimelobacter tumescens AJ 1460 Rhodococcus fascians ATCC 12975 Rhodococcus fascians 1 - isolate of Prof. Dr. Stolp, Univ. Bayreuth Rhodococcus fascians 2 - isolate of Prof. Dr. Stolp,, Univ. Bayreuth - 6 - In the context; of the present invention, only bacterial strains of a few genera of gram-positive eubacfceria have hitherto been investigated to establish whether they possess elicitors and, as far as can b© established from 5 prior publications, of the fungal strains including the yeastse generally only those which were known to be phytopathogenic have been investigated for the presence of elicitor activities. It is therefore to be expected that a large number of other *aicroorganisas, such as, for 10 example, bacteria of the genera Mycobacterium, Nocardia, Nocardioides or Pseudonocardia, can, also be found that likewise possess elicitors.
The examination of microorganisms for elicitor activity can be readily carried out by means of the usual screen-15 ing tests familiar to the person skilled in the art.
For example, in test series the microorganisms the enzyme activity or synthetic capacity of which is to be enhanced can be grown in submerged cultures, inactivated microorganisms of different species or sub-species can 20 be added to the individual cultures and, when fermenta tion is complete , it is possible to determine analytically in which cultures enzyme activities or synthetic capacity have been enhanced. An enhancement of the microorganisms' enzyme activities is recognised, for 25 example, by the fact that an increased rate of formation - or an increased yield - of process product is achieved in the fermentative conversion of substrates. Accordingly, an enhanced synthetic capacity of the microorganisms can be recognised, for example, by an increased rate of - 30 formation - or an increased yield - of components of the microorganism.
As shown by the tests carried out hitherto, which are - 7 - described, in detail in the uorked Examples, the method according to the invention for enhancing enzyme activities or the synthetic capacity of microorganisms seeas to be very versatile. For example, it was possible to 5 stimulate the dyestuff formation of Streptomyces lividans (actinorhodin, prodigiosin) and the dyestuff formation of Streptomyces coelicolor, Streptomyces griseoruber, Streptomyces latericius, Streptomyces purpurascens and Streptomyces violaceus by adding cell wall preparations 10 of Microorganisms listed in Table 2. It was also possible to stimulate the formation of S-lactaro, antibiotics of Streptomyces clavuligerus and the alkaloid synthesis of Claviceps paspali.
Such an enhancement of the synthetic capacity of raicro-15 organisms can be achieved not only by means of the cell preparations of the bacteria listed in Table 2 but it is to b® expected that an enhancement of enzyme activities and the synthetic capacity of microorganisms can be achieved also by means of elici tor-containing fungi and 20 yeasts such as listed in Table 1.
Using cell wall preparations of microorganisms listed in Table 2 it was also possible to obtain a significant increase in alkaloid formation in cell cultures of higher plants,, such as Eschscholtsia californica or Rauvolfia 25 serpentina- It was also possible using those cell wall preparations significantly to enhance the capacity of Bacillus lentus to dehydrogenate steroids in the 1„2-position and the capacity of Rhodotorula glutinis to reduce 17-keto 30 steroids selectively and the capacity of Penicillium raistrickii to hydro: Those tests appear to justify the hop® t£at it will be possible using the method according to tite invention also to stimulate the formation of numerous other industrially applicable microbial components and to enhance other enzyme activities of microorganisms that are susceptible of industrial application.
Such Eiicrolsial components are, for example, antibiotics, such as the penicillins, cephalosporins, cyclosporins, actinomveins, gramicidins, neomycins „ gemtamycins, nystatins, tetracyclines,, nicomycins or lincomycin, erythromycin, chloramphenicol, griseofulvin or fusidic acid, inter alia, ergot alkaloids, such as ergocryptine, ergotamine, ergosine, ergocristine, ergooornine, agro-clavin, chanoclavin, festuclavin, paspalic acid, or lysergic acid derivatives, vitamins, suca as vitamin B 12, riboflavin or fi-carotene? enzymes, such as the amylases» glucose isomerases, proteases, pectinases, cellulases, lipases, penicillin acylases, chitinase or lactase, nucleosides, such as guanylic acid or inosylic acid or, for example, also ajeino acids,, such as cysteine, glutamic acid,, tryptophan or lysine- It should in principle also be possible to enhance the endogenous or exogenous protein formation of genetically modified microorganisms. Such useful proreins are not only the enzymes and antibiotics already sserdtion«2d but also, for example, interferon, insulin, erythropoietin and TNF.
Microorganisxs that are used industrially owing to their enzyme activities are described, for example, in the following publications: W. Charney and Ho Herzog: Microbial Transformations of Steroids? Academic Press, Kew York etc. 1967 K. Kieslich: Microbial Transformations of non-steroidal Cyclic Compounds; Georg Thieme Publ. Stuttgart (Germany), 1976 and K. Kieslich: Biotransformations; in H-J. Reha and G. Heed (editors): Biotechnology: Weinheim (Germany) etc. Vol. 6a, 1984.
Such microorganisms are, inter &UL&, those which bring about steroid transformations such as lla-, 11B- or lSs~ hydroxylation, Aj-dehydrogenation, 17a-, 176-keto reductions ©r the side chain decomposition of sterols or transformations' of antibiotics, such as penicillin cleavage- It is not improbable that it would be possible using the method according to the invention to find new industrially utilisable microbial components, such ss8 for example, new antibiotics, by adding inactive elicitor-containing microorganisms to the microorganisms to be tested.-, That hope is not without foundation because it is known that numerous higher plants form phytoalexins in appreciable quantities only when they are infected with elicitor'-containing microorganisms.
Conventional methods familiar to the person skilled in the art are used to determine what elicitor-containing microorganism enhances the enzyme activities or the synthetic capacity of a specific microorganism.
It is not difficult for the person skilled in the art to carry out the method according to the invention as far a® fermentation by means of microorganisms is concerned. The microorganism the en2yme activity or the synthetic capacity of which is to be enhanced is grown under the - 10 - known conditions? the inactivated elicitor-containing microorganisms, fragments of the same, ceil extracts of the sase or secretions of the same are then added to the culture and fermentation is continued in the customary 5 manner. The addition of the inactivated microorganisms, the fragments or extracts of those higher plants or the secretions of elicitor-containing microorganisms can be effected at the beginning of the fermentation process. The optimum tine for addition naturally depends on the 10 type of microorganism grown, especially on the course of its; exponential growth phase, and must be determined in each individual case. For example, it often proves advantageous in the case of bacteria to effect the addition from 4 to 30 hours after the commencement of 15 fermentation. In the case of the addition of inactivated microorganisms or fragments of the sams, from l to 1000 g Cpreferably ffroia 10 to 200 g) of inactivated microorganism or from 0.1 to 100 g (preferably from 1 to 30 g) of the fragment of that organism are customarily used per 20 j cubic mtetre of fermentation broth. If secretions of elicitor-containing microorganisms are used, it will generally be sufficient to use from 1 to 50 litres of the secretion solution per cubic metre of fermentation vol^aae. If the method according to the invention is used 2 5 to enhance the enzyme activity of a microorganism used for the enzymatic conversion of substrates, the addition of the substrate will generally be started from 0 to 10 hours after the addition of the elicitor-containing inactivated microorganism or its fragments or secretions. 30 The optimum fermentation conditions depend on the type of jnicroorganisM used, the nutrient medium used, the fermentation time, the type and amount: of the elicitor-containing material etc; they have to be determined in each individual case by preliminary tests such as are 35 familiar to the person skilled in the art.
- IX - For the preparation of the inactivated elicitor-containing Microorganisms, the latter are grown under customary conditions,, than separated from the culture medium by centrifugation or filtration, if desired washed and 5 isolated again. Various processes can be used to inactiv ate the microorganisms.
Possible methods of inactivation consist in causing typical substances lethal to cells, such as ethylene oxides, formaldehyde,, ©sons,, mercury compounds or organic 10 solvents, such as methanol, ethanol or acetone., to act on the microorganisms or in killing the microorganisms by heating to fraro 90"C to 140"c, by the influence of extreme pressure differences (disintegration), the action of high-frequency electric fields or by Cjv irradiation, 15 irradiation with Y-rays or the action of ultrasound. The conditions under which inactivation can be carried out are well known to the person skilled in the art (K.H. Wallhauser, H- Schmidt: Sterilisation, Desinfektion, Konservierung, Chemotherapie, Georg Thierae Verlag, 20 Stuttgart (Germany), 1967).
Fragments of elicitor-containing microorganisms can be obtained, for example, by lysis of the microorganisms by the action of osmotic shock or temperature shock, by autolysis of the microorganisms, by treatment of the 2 5 cells with ultrasound or by trituration of the microorganisms with glass beads, powdered glass or quartz sand followed by differential centrifugation (HughesP D.E., Wimpenny, J.W.T. and Lloyd, D.: The disintegration of micro-organisms. In: Methods in Microbiology, Vol- 13, 30 (Norris, J.R. and Ribbons, D.W., eds.) pp. 1-54, Academic Press, Mew York, London, 1971).
Purified cell wall fractions can be obtained from those cell fragments, for example, by trypsin treatment. The cell wall fractions already Mentioned and used in the following worked Examples were prepared in accordance with the method described by Sclileifer and Handler (Arch. Hikrobiol. 52, 1967, 335-365).
On the other hand, it is, however, also possible to prepare elicitor-containing precipitates froa water-soluble cell constituents by precipitation, for example with ethanol or acetone (Kocourek, J- and Ballou, c. E-, J. Bacterial. 100, 1969, 117S-1181).
Secretions of elicitor-containing microorganisms are actively released cell constituents obtained by lysing, making "leaky*, extracting with supercritical liquefied gases (for example carbon dioxide) or heat-sterilising cells in water, water-soluble culture media, or culture media obtained by removing the microorganisms and higher plants by filtration or centrifugation. These can, if necessary, toa further purified, for example by extraction of lipophilic substances,, adsorption of strongly colouring substances, etc..
It has already been mentioned that -he use of enzyme-free elicitor-containing material from bacteria to enhance the synthetic capacity of components of higher plants has been demonstrated experimentally; this could be of importance for the use of plant cell cultures in the preparation of the active ingredients of medicaments (M.H. Sank in: Phsrwazie heutef 103. 1982, Voiu®® 3, 131-138).
The following worked Examples serve no illustrate the invention in detail. - 13 - Example 1 Stimulation of the synthesis of coloured, components (actinorhodin, prodigiosin) in the case of Streptomyces lividans (ATCC 19844) by cell wall preparations. 5 80 ml of a nutrient medium comprising 103 g saccharose 10 g glucose 10 „ 12 g magnesium chloride hexahydrate 0.25 g potassium sulphate 10 0.1 g casaxaino acids (Difco Labs, Detroit/USA) 800 ml distilled water are sterilised (20 minutes, 120*C) and supplemented under sterile conditions with the following freshly prepared solutions. 3 5 1 ml 0.5 % potassium dihydrogen phosphate solution 8 ml 3.68 % calcium chloride dihydrate solution 1.5 ml 20 % L-proline solution 10 ml 5.73 % TES buffer solution (pH 7.2) 20 0.2 ml trace element solution - containing per litre 40 mg 2inc(II) chloride 200 mg iron(lll) chloride hexaftydrate 10 mg copper (II) chloride dihydrate 25 10 mg manganese(II) chloride tetrahydrate 10 rag disodium tetraborate dihydrate 10 mg hexa&wmon iurn heptamolyfodate tetrahydrate 0.5 ml IN sodium hydroxide solution 30 1.8 ml of that nutrient solution are introduced under sterile conditions into each of the 24 3-mi-capacity chambers of a polystyrene multidish (Multidish, manufactured by Nunc, 6200 Wiesbaden 12). 2 mg of the cell wall preparations to ba tested for their elicitor content: are sterilised for 20 minutes at 120 "C in bi-distilled water and the resulting suspensions are added to the chambers. 2 Chambers receive no additions and are used as eostrols,. The volume in all the chambers is uniformly adjusted to 2 ml with Iai-dist:illed water under sterile conditions. Each chamber is inoculated identically with 5 pi of a spore suspension of Streptomyces lividans (ATCC 19844). The test batch Is incubated under aerobic conditions (Tablar shakers 100 revolutions per minute) at 26~C- After 96 hours,, the cells are isolated by centrifugation, washed with physiological saline solution and dried in vacuo over calcium chloride to give the cell yields listed in the Table. The supernatants obtained by centrifugation are adjusted to a pH of 7, diluted to 4 ml with water and their absorption spectra are determined between 180 and 800 na. The relative amounts of the synthesised dissolved secondary substances sctlr.orhodin and prodigiosin are determined approximately by assessing the absorption peaks of the spectra recorded auto'matical-ly.
The following Table 3 shows the results obtained in chat test series. - 15 - TABLE 3 Tested bacterial dry cell dyestuff cell walls of yield (mg) content rel. absorp- 5 ... tion u: without (control) 22 1 B. amnioniagenes (ATCC 6872) 25 38 B, glutassingenes (ATCC 13747) 32 24 Ba - piutilus (ATCC 7061) 34 2 B. linens (ATCC 19391) 23 1 C. diphtheriae (Mass. 8) 24 34 C. raelassecoia (ATCC 17965) 26 34 c. glutamicuffi (ATCC 13032) 43 50 c. liliun (ATCC 15990) 33 40 ce . cellasea (ATCC 14359) 35 2 L. piantarum (DSM 20174) 32 31 S. aureus strain H 44 1 B = Brevibacteriura Ba = Bacillus 2o C = Corynebacter iuia Ce = Cellulosnonas L = Lactobacillus S = Staphylococcus Exaianle 2 2 5 Stimulation of the synthesis of coloured components (actinorhodin, prodigiosin) in the case of Streptomyces lividans (ATCC 19844) by cell wall extracts.
Under the conditions of Example l, but using the sterile filtrates of the 2-rag cell wall preparations sterilised 30 for 20 minutes at 120"C in bi-distilled water,, a stimula - ifi - tion of dyestuff formation is achieved in Streptomyces lividans (ATCC 19844) that is almost as strong as when using suspensions of those sterilised cell walls.
Example 3 5 Stimulation of the synthesis of coloured components (actinorhodin„ prodigiosin) in the case of Streptomyces lividans (ATCC 19844} lay cell extracts.• Under the conditions of Example 2, but using 20 mg of biomass instead of 2 mg of cell wall preparation, a 10 stimulation of dyesrtuff formation is achieved that is approximately equally as strong as whan using suspensions of the sterilised cell walls. £2£3bib1ILJL Stimulation of the synthesis of coloured components in 15 the case of Streptomyces coelicolor A3(2) or (ATCC 13 405).
Under the conditions of Exaiaple 1, but using Streptomyces coelicolor A3(2)p a marked stimulation of dvestufr formation (probably likewise actinorhodin) is achieved in 20 the case of this bacterium.
Example 5 Stimulation of the synthesis of coloured components in the case of Streptomyces griseoruber (DSH 40275).
Under the conditions of Example 1, but using Streptomyces 25 griseoruber (DSH 40275), a very marked increase in dyestuff formation (presumably anthracyclin antibiotics) is achieved in the case of this bacterium also. - 17 - Exa«nle_6.
Stimulation of the synthesis of coloured components in the case of Streptomyces purpurascens (DSH 40 310), Under the conditions of Example i, but using Streptomyces 5 purpurascens (DSH 40 310) , a distinct increase in dyestuff formation (presumably likewise anthracyclin antibiotics) is achieved in the case of this bacterium also* 10 Stimulation of the synthesis of coloured components in the case of Streptomyces latericius (DSH 40 163)- Under the conditions of Example 1, but using Streptomyces latericius (DSH 40 163), a significant increase in dyestuff formation is achieved in the case of this bac-15 teriu® also.
Example § Stimulation of the synthesis of coloured components in the case of Streptomyces violaceus (DSK 40 082).
Under the conditions of Example 1, but using Streptomyces 20 violaceus (DSM 40 082), a significant increase in dyestuff formation is achieved in the case of this bacterium also. - 18 - Example 9 Stimulation of the formation of G-lactaia antibiotics (cephalosporins,, penicillin N) by Streptomyces clavuli-gerus (ATCC 27064). 5 g 3-(M—marpholino)-propanesulphonic acid (HOPS) 3»5 g - dipotassiun hydrogen phosphate 0.6 g magnesium sulphate heptahydrate 2 g L~asparagin@ 10 g glycerol 1 g yeast extract (Oxide, Wesel, Germany) 1 ml trace element salt solution - containing per litre l g iron(XI) sulphate heptahydrate 1 g manganese(II) chloride tetrahydrate 1 g zinc chloride heptahydrate l g calcium chloride are made up to 1 litre with distilled water and sterilised (20 minutes? 120*C) - 1.8 ml of that nutrient solution are introduced under sterile conditions into each of the 3-ml~capacity chambers of a sterile polystyrene multidish (Multidish; manufactured by Nunc, 62 Wiesbaden 12). 2 mg of the cell wall preparations to be tested for elicitor activity or 10 mg of the cells to be tested are added in the form of homogeneous suspensions sterilised in bi-distilled water (20 and 45 minutes, respectively, 120"C). Two chambers serving as control receive no additions„ The volume in all the chambers is then uniformly adjusted to 2 ml with bi-distilled water under sterile conditions. Each chamber is inoculated identically with 5 nl of a spore suspension of Streptomyces clavuligerus (ATCC 27064).
The incubation of the test series is carried out under - 19 - aerobic conditions (Tablar shaker? 160 revolutions per minute) at 26"C. The incubation time is fross 24 to 48 hours.
The formation of antibiotics is examined in comparison with the controls using the plate diffusion test:. The detector organisms suspended in soft: nutrient agar are Micrococcus luteus and Bacillus suhtilis (3.0® cells per si). 25 /*1 of centrifuged (48,000 x g) culture medium from the test chambers are applied to each of a number of standard filter pistes (0,9 cm diameter}- After a diffusion time of 4 hours at 4*c, the biotest is incubated for 24 hours at 30"c.
In the case of the cultures that were grown with the addition of killed cells of Brevibacterium flavura ATCC 13826 or of cell wall preparations of that bacterium or of call wall preparations of Corynebacterium diphtherias (strain Mass. 8), clearly enlarged inhibiting areolas exhibited an increased formation of B-l&ctam antibiotics (penicillin M, cephalosporins) by Streptomyces clavuli-gerus compared with the controls.
Example 10 Stimulation of the formation of alkaloids (sanguinarine, chelirubine, marcarpine and chelerythrine) by cultures of Eschscholtzia californica.
Tissue cultures of Eschscholtzia californica are gro'^r, in each of 24 1-ial chambers of a polystyrene multidish (manufactured by Nunc, 6200 Wiesbaden 12) under the conditions described as optimum by J. Berlin al. (Z. Naturforsch., 38 Table 4 below shows the results obtained in this test j0 series.
TABUS 4 Tested, bacterial cell vails % elicitor activity Brevibacterium bwtsnicws ATCC 21196 19 15 Brevibacterium flavum ATCC 13826 16 Brevibacterium £lavum ATCC 14067 30 Brevibacterium glutamingenes ATCC 137 113 Brevibacterium lactofena@ntum ATCC 13655 43 Brevibacterium anunoniagenes ATCC 6872 4 0 20 Corynebacterium hydrocarboc 1 ast urn ATCC 15592 8 Corynebacteriurn nephridii ATCC 11425 123 Corynebacteriurn paurometabolum ATCC 8368 16 Corynebacterium liliua ATCC 15990 108 Corynebacterium striatum ATCC 6940 17 25 Corynebacter ium petrophilua ATCC 19080 0 Corynebacter ium xerosis ATCC 373 102 Corynebacter ium diphtherias strain Mass. 8 137 Rhodococcus fascians ATCC 12975 27 Rhodococcus fascians 1 11 30 isolate of Prof. Dr. Stolp, Univ. Bayreuth Rhodococcus faseians 2 7 isolate of Prof. Dr. Stolo. Univ. Bavreuth - 21 - Example 1.1 Stimulation of the formation of indole alkaloids (valles-iacotamine) in cultures of Rauvolfia serpentina.
A suspension culture of Rauvolfia serpentina (Stockist,, 5 J., A. Pfitzner and J. Firl: Plant Cell Rep. JL, 36-3® (1981) is cultivated in Linsnaier and Skoog (LSJ-nediun (Physiol. Plantar-urn UL 100-127 (1965) on rotary shakers (100 revolutions per minute) at 23"C with permanent light (60S lux) _ For elicitation, 20© g of cell fresh 10 weight/1 LS siediua are inoculated. Cell wall preparations of the bacteria listed in Table 4 are used at a concentration of 130 sag/1 iaadius as elicitor-containing fragments of microorganisms™ After 5 days41 incubation, the biomass has doubled both in 15 the elicited cultures and in the controls. The cells are harvested and extracted with Methanol.
The amount of the indole alkaloid vallesiacotamine is determined by separating the extracts by KPLC. Whereas the untreated control cultures contain only 1.16 mg/1 of 20 medium, the yield in the case of the elicited cultures is a naxiroum of 58 sag/1. That corresponds to a 50-fold increase by the elicitor.
Stimulation of the 17-keto steroid reductase activity of Rhodotorula glutinis XFO 0389. a) A 2-litre Erleniaeyer flask with 500 ml of sterile nutrient medium containing 5 % glucose monohydrate - 22 - 2 % cornsteep liquor - adjusted to pH 6.5 - is inoculated with a smear from a slant agar culture of Rhodotorula glutinis IFG 0389 and cultivated for 40 hours at 30"C and at 190 revolutions per minute.
A SOO-ssi Erlenmeyer flask with 100 ml of sterile nutrient medium containing 1 % cornsteep liquor 5 % Nurupan (R) (manufacturer Nurupan GabK, 4000 Dusseldorf 1? Germany) 1 % Meter in (R) (manufacturer Lucas Meyer; 2000 Hamburg 28; Germany) - adjusted to pH 6.2 - is inoculated with 10 ml of the Rhodotorula pre-culture prepared in accordance with Example 12a and cultivated for 7 hours at 30*C and 180 revolutions per minute. 10 tag of 3-hydroxy-l,3,5(10) ,7-oestratetraen-i7-one are then added to the culture and fermentation is effected for © further 210 hours. The culture is then extracted with methyl isobutyl ketone, the extract is concentrated and the resulting crude product is purified by chromatography on a silica gel column to yield 5.9 mg of 1,3,5(10) ,7-oestra-tetraene-3 „ 17a~diol = 59 % of the theoretical yield. 10 sg of 3-hydroxy-l ,3,5(10), 7-oestratetraen-17-one are fermented with a culture of Rhodotorula glutinis under the conditions of Example 12b except that 5 ml of a sterile suspension of 50 mg of a cell wall preparation of Bacillus licheniformis (ATCC 9945) in water are added to the culture immediately before the addition of the substrate. After working up the culture, 6.8 lag of 1,3,5(10),7-oestratetraene-3,17- diole = 68 % of the theoretical yield are obtained.
SXSffiai£__L3.
Stimulation of the steroid A ^-dehydrase activity of Bacillus lentus (ATCC 13805). a) A 2-litre Erlerraeyer flask with 500 al of sterile nutrient solution containing 0.5 % cornsteep liquor 0.05 % glucose raonohydrate 0.1 % yeast extract - adjusted to pH 7.0 - is inoculated with a rinse of Bacillus lentus (ATCC 13 805) and shaken for 48 hours at 30"C and at 190 revolutions per minute. b) A 500—sfol Erienneyer flask with, 100 al of sterile nutrient solution containing 3.0 % soya powder 0.5 % cornsteep liquor 0.1 % yeast extract 0.05 % glucose monohydrate - adjusted to pH 7.3 - is inoculated with 10 ml of the Bacillus lentus preculture and shaken for 7 hours at 30"C and at 180 revolutions per minute. A sterile-filtered solution of 40 tag of 6cr, 9a-dif luoro-llS, l?a-dihydroxy-16c:-methyl-4-pregnene-3,20-dione in 4 »l of dimethyl-formauide is then added to the culture and the whole is incubated for a further 41 hours.
The culture is then extracted with methyl isobutyl ketone, the extract is concentrated in vacuo and the residue is purified by chromatography on a - 24 - silica gel column to yield 16 mg of 6 c, 9 Stimulation of the formation of alkaloids (lysergic acid amide and isolysergic acid asaide) by Claviceps paspali (ATCC 13895). a) A 500-sul Erlenmeyer flask with 50 ml of a sterile nutrient solution containing 4 % sorbitol (industrially pure) 1 % glucose monohydrate 2 % succinic acid 0.6 % ammonium sulphate 0.5 % yeast extract (DifcoW manufactured by Diffco Labs. Detroit/USA) 0.1 % potassium dihydrogen phosphate 0.03 % magnesium sulphate heptahydrate -adjusted to pH 5.2 with sodiua hydroxide solutionis inoculated with a culture of Claviceps paspali (ATCC 13895) deep-frozen to -70"c and shaken for 5 days at 24"c and 240 revolutions per minuta. - 25 - k 5QQ-k1 Erlermeyer flask with 50 sal of a sterile nutrient: solution containing a t 6 % Sufficient sodium hydroxide solution is then added to the culture to adjust the pH to at least 10, extraction is carried out with kgthy1 isobutyl ketone and the extracts are concentrated in vacuo and purified by chromatography on a silica gel coluffln* 35 mg of a mixture of lysergic acid aside and isolysergic acid asaide (yield 700 ng/1 of culture) are thus obtained.
A culture of Claviceps paspali is grown under the conditions of Example 14b except that 5 ml of a sterile suspension of 25 rag of cell wall preparation of Lactobacillus casei subsp. rhamnosus (ATCC 7469) in water are added to the culture after 72 hours. After working up the culture, 45 mg of a mixture of lysergic acid amide and isolysergic acid 26 - amide (yield 900 ag/1 of culture) are obtained, Stimulation of the 15c:~hydroxylas
Claims (7)
1. Method of enhancing enzyme activities and the synthetic capacity of microorganisms and higher plants, characterised in that the sane are brought into contact 5 with inactivated elicitor-containing microorganisms, fragments of the saiae or secretions of elicitor-containing aicroorganissas P with the proviso that, in order to enhance enzyme activities and the synthetic capacity of higher plants,, inactivated elicitor-containing bacteria, 10 fragments of the same or secretions of elicitor-containing bacteria are used.
2. « Method of enhancing enzyme activities and the synthetic capacity of aicroorganisas according to patent clain l, characterised in that the same are brought into 15 contact with inactivated elicitor-containing Microorganisms , fragments of the sawe or secretions of elicitor-containing microorganisms-
3. Method of enhancing the synthetic capacity of nicro-organisms according to patent claiu 2, characterised in 20 that bacteria, fungi and. yeasts capable of forming dyestuffs, alkaloids or antibiotics are brought into contact with inactivated elicitor-containing bacteria, fungi or yeasts, fragments of the same or secretions of those microorganisms. 25
4. Method of enhancing enzyme activities of issicro- organisms according to patent claia 2, characterised in that bacteria,, fungi or yeasts capable of steroid transformation are brought into contact with inactivated elicitor-containing bacteria, fungi or yeasts, fragments 30 of the sasne or secretions of those microorganisms.
5. Method of enhancing the synthetic capacity of higher - 29 - plants according to patent claim 1, characterised in chat; cell cultures of higher plants capable of dyestuff synthesis, alkaloid synthesis or phytoalexin synthesis are brought into contact with inactivated elicitor-5 containing bacteria, fragments of the same or secretions of those bacteria.
6. Method of enhancing enzyme activities and the synthetic capacity of microorganisms and higher plants according to patent claims l to 5, characterised in that SO the sasae are broaght into contact with elicitor-containing aicroorganisES heat-sterilised in water, or with filtrates of the sasse-
7. . A ■ ne shod subscatnc ial ly as bereinbe fore described with reference Co the Exaraples. Dated Chis !31h day of January 1989 CSDXCKSRAHK & CO. Agents for the applicant 1 Holies Scraet Dublin 2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3801023A DE3801023A1 (en) | 1988-01-13 | 1988-01-13 | METHOD FOR INCREASING ENZYME ACTIVITIES AND THE SYNTHETIC PERFORMANCE OF ORGANISMS |
Publications (2)
Publication Number | Publication Date |
---|---|
IE890079L true IE890079L (en) | 1989-07-13 |
IE66500B1 IE66500B1 (en) | 1996-01-10 |
Family
ID=6345349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE7989A IE66500B1 (en) | 1988-01-13 | 1989-01-13 | Method for increasing enzyme activities and synthesis performance of organisms |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0354945B1 (en) |
JP (1) | JPH02502881A (en) |
CN (1) | CN1034756A (en) |
AT (1) | ATE103325T1 (en) |
AU (2) | AU3215989A (en) |
BG (1) | BG60596B1 (en) |
CA (1) | CA1317247C (en) |
DD (1) | DD278357A5 (en) |
DE (2) | DE3801023A1 (en) |
DK (1) | DK442289A (en) |
ES (1) | ES2051894T3 (en) |
FI (1) | FI97302C (en) |
HU (1) | HU208341B (en) |
IE (1) | IE66500B1 (en) |
IL (1) | IL88953A (en) |
NO (1) | NO893643L (en) |
PT (1) | PT89427B (en) |
WO (1) | WO1989006687A1 (en) |
ZA (1) | ZA89304B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7264951B1 (en) | 1992-02-20 | 2007-09-04 | Phyton, Inc. | Enhanced production of taxol and taxanes by cell cultures of Taxus species |
KR20090005241A (en) | 1996-05-24 | 2009-01-12 | 디에프비 바이오테크 인코포레이티드 | Enhanced production of taxanes by cell cultures of taxus species |
GB9611089D0 (en) * | 1996-05-28 | 1996-07-31 | Sandoz Ltd | Organic compounds |
US10749991B2 (en) | 2017-05-31 | 2020-08-18 | Regents Of The University Of Minnesota | Emulation-based cross-technology communication |
CN107746849B (en) * | 2017-09-29 | 2022-01-18 | 天津科技大学 | Efficient screening method of steroid hydroxylase genes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1259938A (en) * | 1985-12-05 | 1989-09-26 | Friedrich Constabel | Repeated elicitor treatment, a method for semicontinuous metabolite production by plant cells cultured in vitro |
-
1988
- 1988-01-13 DE DE3801023A patent/DE3801023A1/en not_active Withdrawn
-
1989
- 1989-01-11 ES ES89100337T patent/ES2051894T3/en not_active Expired - Lifetime
- 1989-01-11 HU HU89975A patent/HU208341B/en not_active IP Right Cessation
- 1989-01-11 EP EP89901715A patent/EP0354945B1/en not_active Expired - Lifetime
- 1989-01-11 DE DE89901715T patent/DE58907274D1/en not_active Expired - Lifetime
- 1989-01-11 AU AU32159/89A patent/AU3215989A/en not_active Abandoned
- 1989-01-11 AT AT89901715T patent/ATE103325T1/en not_active IP Right Cessation
- 1989-01-11 EP EP89100337A patent/EP0325933B1/en not_active Expired - Lifetime
- 1989-01-11 WO PCT/EP1989/000015 patent/WO1989006687A1/en active IP Right Grant
- 1989-01-11 DD DD32499389A patent/DD278357A5/en not_active IP Right Cessation
- 1989-01-11 JP JP1501513A patent/JPH02502881A/en active Pending
- 1989-01-12 PT PT89427A patent/PT89427B/en not_active IP Right Cessation
- 1989-01-12 CA CA000588110A patent/CA1317247C/en not_active Expired - Fee Related
- 1989-01-13 CN CN89100184A patent/CN1034756A/en active Pending
- 1989-01-13 IL IL8895389A patent/IL88953A/en not_active IP Right Cessation
- 1989-01-13 ZA ZA89304A patent/ZA89304B/en unknown
- 1989-01-13 IE IE7989A patent/IE66500B1/en not_active IP Right Cessation
- 1989-09-07 DK DK442289A patent/DK442289A/en not_active Application Discontinuation
- 1989-09-12 FI FI894304A patent/FI97302C/en not_active IP Right Cessation
- 1989-09-12 NO NO89893643A patent/NO893643L/en unknown
- 1989-09-13 BG BG89739A patent/BG60596B1/en unknown
-
1992
- 1992-11-05 AU AU28183/92A patent/AU2818392A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3215989A (en) | 1989-08-11 |
WO1989006687A1 (en) | 1989-07-27 |
DD278357A5 (en) | 1990-05-02 |
IL88953A0 (en) | 1989-08-15 |
ATE103325T1 (en) | 1994-04-15 |
DE58907274D1 (en) | 1994-04-28 |
FI97302B (en) | 1996-08-15 |
HUT57270A (en) | 1991-11-28 |
PT89427A (en) | 1990-02-08 |
CN1034756A (en) | 1989-08-16 |
EP0325933A1 (en) | 1989-08-02 |
EP0354945B1 (en) | 1994-03-23 |
CA1317247C (en) | 1993-05-04 |
HU208341B (en) | 1993-09-28 |
FI894304A0 (en) | 1989-09-12 |
IL88953A (en) | 1995-03-30 |
DK442289D0 (en) | 1989-09-07 |
EP0354945A1 (en) | 1990-02-21 |
PT89427B (en) | 1993-09-30 |
BG60596B1 (en) | 1995-09-29 |
AU2818392A (en) | 1993-01-14 |
NO893643D0 (en) | 1989-09-12 |
NO893643L (en) | 1989-09-12 |
ES2051894T3 (en) | 1994-07-01 |
EP0325933B1 (en) | 1994-03-09 |
IE66500B1 (en) | 1996-01-10 |
JPH02502881A (en) | 1990-09-13 |
FI97302C (en) | 1996-11-25 |
ZA89304B (en) | 1989-10-25 |
DE3801023A1 (en) | 1989-07-27 |
DK442289A (en) | 1989-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus | |
JPS5910798B2 (en) | New method for producing rifamycins | |
IE890079L (en) | Method for increasing enzyme activities and synthesis performance of organisms | |
US5407826A (en) | Isolated cultures of microorganisms of Clonostachys Cylindrospora, Gliocladium and Nectria Gliocladioides | |
El-sersy et al. | Antagonistic effect of marine Nocardia brasiliensis against the fish pathogen Vibrio damsela: Application of Plackett | |
KR100319837B1 (en) | Enzymatic Asymmetric Reduction Method for the Preparation of 4H-Tieno (2,3-6) thiopyran Derivatives | |
CN110862953A (en) | Preparation and germination method and application of geobacillus stearothermophilus spores | |
FR2546180A1 (en) | PROCESS FOR INCREASING ANTIBIOTIC PRODUCTION BY GENETIC RECOMBINATION IN VIVO | |
Bhosale et al. | Optimization and characterization of antifungal metabolite from a soil actinomycete Streptomyces indiaensis SRT1 | |
Skotnicki et al. | Bacterial and bacteroid properties of mutants of Rhizobium trifolii strain T1 uncoupled in oxidative phosphorylation | |
WO1995034558A1 (en) | Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production | |
Bae et al. | Isolation of bacterial strain antagonistic to Pyricularia oryzae and its mode of antifungal action | |
JPS61247396A (en) | Production of genisteine | |
WO1990010010A1 (en) | New substance trehalostatin and production thereof | |
EP0284358B1 (en) | Novel anti-tumor compounds, method for the preparation thereof, and pharmaceutical preparations containing them | |
JP3796540B2 (en) | Method for producing yellow pigment | |
JPS59166094A (en) | Preparation of physiologically active substance ml-236b | |
JPH05207894A (en) | Production of macrolide antibiotic | |
JPH0438390B2 (en) | ||
JPS6272691A (en) | Novel physiologically active substance no.1328 and production thereof | |
JPS5843796A (en) | Preparation of androstane compound by microorganism | |
JPH0117678B2 (en) | ||
JPS5852277A (en) | Novel antibiotic y-t 0678h substance and its preparation | |
JPH08277290A (en) | New chitinase-inhibiting substance and its production | |
JPH07289274A (en) | Production of trans-4-hydroxy-l-proline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |